Interface Polymers has secured funding as it prepares to shape its materials adhesive concept into a commercial product.

Ultrasound simulator developer Medaphor will pay up to $4.9m in shares to acquire University of Oxford spinout Intelligent Ultrasound.

AbbVie Ventures is among the backers of a $30m series A round for Disarm Therapeutics, a biotechnology spinout from Washington University in St Louis.

AbbVie Ventures is among the backers of a $30m series A round for Disarm Therapeutics, a biotechnology spinout from Washington University in St Louis.

The Engine has already made seven investments in a bid to commercialise technologies that require a longer-term view than most.

Neurological drug developer Rodin Therapeutics has now raised more than $57m in total, its past investors including Johnson and Johnson and Biogen.

Uqar spinout Ovensa has obtained $1.38m of additional funding from investors including commercialisation firm Aligo Innovation.

Bill & Melinda Gates Foundation will invest up to $40m in the biological drug developer, which raised $320m in an Eli Lilly-backed round two years ago.